Streamex Corp Receivables Turnover Ratio (STEX), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Streamex Corp   (NASDAQ: STEX)
 

Streamex Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Streamex Corp 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 4.86, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Streamex in Jun 30 2026 quarter, has decreased to 75 days, compared to 664 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector Streamex Corp achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Streamex Corp Selling?


What is Receivable Turnover Ratio?





STEX Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 390.91 % -50.46 % -89.91 % -86.42 % -79.63 %
Y / Y Revenue Change - - - - -
Receivable Turnover Ratio (TTM) 4.86 0.55 - 0.22 0.17
STEX's Total Ranking # # # # #
Accounts Receivable average collection period days 75 662 - 1685 2176
Seq. Receivable Change 0 % 390.91 % 0 % 0 % -89.91 %
Seq. Revenue Change 1116.67 % - - - -


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 






Financial Statements
Streamex 's Accounts Receivable $ 0 Millions Visit STEX's Balance sheet
Streamex 's Sales TTM $ 0 Millions Visit STEX's Income Statement
Sources of STEX's Revenues Visit STEX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
STEX's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
STEX's Growth Rates STEX's Roa STEX's Inventory Turnover Ratio STEX's Dividend Comparisons
STEX's Profitability Ratios STEX's Roi STEX's Asset Turnover Ratio STEX's Dividend Growth
STEX's Valuation Ratios STEX's Roe STEX's Financial Strength Ratios STEX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Alphatec Holdings Inc   7.94 $ 814.780  Millions$ 102.662  Millions
Tenet Healthcare Corp  7.92 $ 21,812.000  Millions$ 2,752.500  Millions
Henry Schein Inc   7.91 $ 13,602.000  Millions$ 1,719.000  Millions
Pacs Group Inc   7.78 $ 5,551.038  Millions$ 713.483  Millions
Vycor Medical Inc   7.68 $ 1.807  Millions$ 0.235  Millions
Idexx Laboratories Inc  7.65 $ 4,553.792  Millions$ 595.549  Millions
Sharps Technology Inc   7.65 $ 2.468  Millions$ 0.323  Millions
Natera Inc   7.61 $ 2,707.077  Millions$ 355.618  Millions
Quest Diagnostics Inc  7.56 $ 11,560.000  Millions$ 1,529.250  Millions
Iridex Corp  7.49 $ 51.044  Millions$ 6.816  Millions
Novocure Limited  7.46 $ 699.193  Millions$ 93.686  Millions
Intuitive Surgical Inc   7.46 $ 11,296.300  Millions$ 1,513.950  Millions
Beta Bionics Inc   7.43 $ 119.513  Millions$ 16.092  Millions
Maravai Lifesciences Holdings Inc   7.39 $ 207.886  Millions$ 28.147  Millions
Foxo Technologies Inc   7.27 $ 24.846  Millions$ 3.420  Millions
Safe Pro Group Inc   7.23 $ 2.881  Millions$ 0.399  Millions
Rhythm Pharmaceuticals Inc   7.18 $ 239.918  Millions$ 33.429  Millions
Angiodynamics Inc   7.08 $ 317.726  Millions$ 44.853  Millions
Pulmonx Corporation  7.07 $ 87.393  Millions$ 12.356  Millions
Edwards Lifesciences Corporation  6.98 $ 6,512.500  Millions$ 933.400  Millions
Universal Health Services Inc   6.95 $ 18,646.705  Millions$ 2,683.492  Millions
Quidelortho Corp  6.92 $ 2,674.200  Millions$ 386.400  Millions
Myriad Genetics Inc   6.91 $ 805.900  Millions$ 116.650  Millions
Ceribell Inc   6.90 $ 101.804  Millions$ 14.749  Millions
Nephros Inc   6.83 $ 21.686  Millions$ 3.173  Millions
Medpace Holdings Inc   6.82 $ 2,782.288  Millions$ 408.189  Millions
Opko Health Inc   6.79 $ 587.896  Millions$ 86.589  Millions
Rapid Micro Biosystems Inc   6.76 $ 34.545  Millions$ 5.111  Millions
3m Company  6.72 $ 25,180.000  Millions$ 3,747.750  Millions
Phibro Animal Health Corporation  6.70 $ 1,516.861  Millions$ 226.555  Millions

Date modified: 2026-08-16T09:05:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.